Browsing: Policy

On Wednesday night in Clive, Iowa, a parade of Make America Healthy Again activists and Republican candidates decried Big Agriculture, stressed the rise in chronic disease in America, and called for the Covid-19 vaccine to be removed from the market. 

The middlemen that oversee prescription drug spending for employers and workers will soon have to tell their clients all the different ways they get paid, a significant move that will unlock reams of highly protected data.

The Department of Health and Human Services released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products, increasing access to the experimental wellness therapies embraced by many in the Make America Healthy Again movement

A House lawmaker asked the Government Accountability Office to review whether the TrumpRx platform has saved Americans any money.

The Food and Drug Administration published draft guidance on Tuesday that would streamline approvals of some individualized gene therapies, a win for rare disease advocates who have criticized the agency’s approach to these treatments

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Missouri Attorney General Catherine Hanaway (R) has warned Eli Lilly to discontinue its practice of requiring hospitals to provide claims data to receive discounted medicines under a federal program, a sign that more states are pushing back against such moves by drugmakers.

OpenAI recently announced that it is tracking signs of user distress across sessions, rather than only within them, and using that information to inform model responses. The announcement follows a wave of new safeguards for mental health and well-being conversations with artificial intelligence at OpenAI and elsewhere, such as parental controls for teens, usage limits…

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

A House lawmaker is investigating whether the three largest pharmacy benefit managers targeted independent pharmacies with audits in retaliation for supporting a bill that would require the companies to adjust payments to the retailers.